quinolizines - CISMeF

Preferred Label : quinolizines;

MeSH annotation : do not confuse with QUINOLINES;

Is substance : O;

Details

Origin ID

D011807;

UMLS CUI

C0034429;

Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Currated CISMeF NLP mapping
- Quinolizine (substance) [SNOMED CT concept]
Ne pas confondre avec
- quinolines [MeSH Descriptor]
Record concept(s)
- quinolizines [MeSH concept]
Related MeSH Supplementary Concept(s)
- (2-carboxy-2-cyanovinyl)julolidine farnesyl ester [MeSH Supplementary Concept]
- 1,2,3,4,6,7,12,12b-octahydroindolo(2,3-a)quinolizine [MeSH Supplementary Concept]
- 1,2-bis-N-cytisinylethane [MeSH Supplementary Concept]
- 1,3,4,6,7,11b-hexahydro-9,10-dimethoxy-2H-benzo(a)quinolizine-2-spiro-3'-(1'-phenyl)succinimide [MeSH Supplementary Concept]
- 1-((4-cyano-4-(pyridine-2-yl)piperidin-1-yl)methyl)-4-oxo-4H-quinolizine-3-carboxylic acid [MeSH Supplementary Concept]
- 1-((4-cyano-4-pyridin-2-ylpiperidin-1-yl)methyl)-4-oxo-4H-quinolizine-3-carboxylic acid [MeSH Supplementary Concept]
- 1-ethyl-1,2,3,4,6,7-hexahydroindolo(2,3-a)quinolizinium [MeSH Supplementary Concept]
- 1-methyl-4-(1-pent-2-en-4-ynyl)quinolizidine [MeSH Supplementary Concept]
- 10-hydroxylycopodine [MeSH Supplementary Concept]
- 10-methylaminododecahydro-3a,7a-diazabenzo(de)anthracene-8-thione [MeSH Supplementary Concept]
- 12-hydroxysophocarpine [MeSH Supplementary Concept]
- 14-hydroxyoxymatrine [MeSH Supplementary Concept]
- 1H,4H-quinolizinium-7-olate [MeSH Supplementary Concept]
- 2,3,5,6-tetrahydro-4,8-dimethylbenzo(c)quinolizin-3-one [MeSH Supplementary Concept]
- 2-(4-chlorophenyl)-1,3-dicyano-6,7-dihydro-4-imino-9,10-dimethoxybenzo(a)quinolizine [MeSH Supplementary Concept]
- 2-(hydroxymethyl)-1-((7-oxo-8-phenyl-7H-thieno(2,3-a)quinolizin-10-yl)carbonyl)pyrrolidine [MeSH Supplementary Concept]
- 2-chlorodithiane [MeSH Supplementary Concept]
- 2-hydroxy-4-(3-hydroxy-4-methoxyphenyl)-trans-quinolizidine [MeSH Supplementary Concept]
- 2-tert-butyl-7-(2,4-dichlorophenyl)octahydro-2H-quinolizin-2-ol [MeSH Supplementary Concept]
- 3,12-dimethyloctahydroindol-(2,3-a)quinolizine [MeSH Supplementary Concept]
- 3-(2-furyl)-8-((2-furyl)methyl)-4,5-bis(hydroxy-methyl)-1-oxo-1H,4H-quinolizinium-7-olate [MeSH Supplementary Concept]
- 3-(hydroxy-4,4-dimethyl-2-oxo-3-quinolizidyl)-4-quinazolinone [MeSH Supplementary Concept]
- 3-(hydroxymethyl)-6,7-dihydroindolo(2,3-a)quinolizin-(12H)-one [MeSH Supplementary Concept]
- 3-acetyl-4-oxo-6,7-dihydro-12H indolo(2,3-a)quinolizine [MeSH Supplementary Concept]
- 3-bromocytisine [MeSH Supplementary Concept]
- 3-iodocytisine [MeSH Supplementary Concept]
- 4,12-dihydroxylycopodine N-oxide [MeSH Supplementary Concept]
- 4,13-dihydroxy-2,8,9-trimethoxydibenzo(a,g)quinolizinium [MeSH Supplementary Concept]
- 4-allyl-8-ethylquinolizidine [MeSH Supplementary Concept]
- 4-methyl-benzo(c)quinolizin-3-one [MeSH Supplementary Concept]
- 5,6-dihydrodibenzo(a,g)quinolizinium [MeSH Supplementary Concept]
- 5,6-dihydroflavopereirine [MeSH Supplementary Concept]
- 5-butyl-6-hydroxy-10-chlorobenzo(c)quinolizinium chloride [MeSH Supplementary Concept]
- 5-butyl-7-chloro-6-hydroxybenzo(c)quinolizinium [MeSH Supplementary Concept]
- 55P0110 [MeSH Supplementary Concept]
- 6-hydroxy-10-chlorobenzo(c)quinolizinium [MeSH Supplementary Concept]
- 7-hydroxyflumequine [MeSH Supplementary Concept]
- 7-hydroxylycopodine [MeSH Supplementary Concept]
- 7-hydroxyxestospongin A [MeSH Supplementary Concept]
- 7-methoxycryptopleurine [MeSH Supplementary Concept]
- 8,10-bis((2,2-dimethyl-1-oxopropyl)oxy)-11-methyl-1234-tetrahydro-6H-benzo(beta)quinolizin-6-one [MeSH Supplementary Concept]
- 8,15-dehydro-5,6-dihydrolycopodine [MeSH Supplementary Concept]
- 8-chloro-2,3,5,6-tetrahydro-4-methylbenzo(c)quinolizin-3-one [MeSH Supplementary Concept]
- 8-hydroxy-2,3,6,7-tetrahydro-1H,5H-pyrido(3,2,1-ij)quinoline-9-carbaldehyde [MeSH Supplementary Concept]
- 9(10)-dehydroquinolizidine [MeSH Supplementary Concept]
- 9-(2,3,5,6,8,9,11,12-octahydro-1,4,7,10,13-benzopentaoxacyclopentadecin-15-yl)-aminobenzo(b)quinolizinium [MeSH Supplementary Concept]
- 9-(2-(1,4-dioxa-7,13-dithia-10-azacyclopentadecyl)phenyl)amino-benzo(b)quinolizinium [MeSH Supplementary Concept]
- 9-(2-carboxy-2-cyanovinyl)julolidine [MeSH Supplementary Concept]
- 9-(4-dimethylaminophenyl)benzo(b)quinolizinium [MeSH Supplementary Concept]
- 9-(dicyanovinyl)julolidine [MeSH Supplementary Concept]
- 9-amino-9-deoxyepiquinine [MeSH Supplementary Concept]
- 9-bis(pyridin-2-ylmethyl)aminobenzo(b)quinolizinium [MeSH Supplementary Concept]
- 9-methyl-1,2,3,4,6,7,12,12b-octahydro-7-oxo-indolo(2,3-a)quinolizine [MeSH Supplementary Concept]
- 9-methyl-1,2,3,4,6,7,12,12b-octahydroindolo(2,3-a)quinolizine [MeSH Supplementary Concept]
- A 58365B [MeSH Supplementary Concept]
- A 86719.1 [MeSH Supplementary Concept]
- ATIQCTPC compound [MeSH Supplementary Concept]
- BMY 27709 [MeSH Supplementary Concept]
- BRL 20627 [MeSH Supplementary Concept]
- C 525 [MeSH Supplementary Concept]
- D 2097 [MeSH Supplementary Concept]
- EMD 16139 [MeSH Supplementary Concept]
- F 91873 [MeSH Supplementary Concept]
- F 91874 [MeSH Supplementary Concept]
- GPA 2640 [MeSH Supplementary Concept]
- HSR 740 [MeSH Supplementary Concept]
- JB 1-0 [MeSH Supplementary Concept]
- L 657743 [MeSH Supplementary Concept]
- N-(1,3,4,6,7,12b-hexahydro-2H-benzo(b)furo(2,3-a)quinolizin-2-yl)-N-methyl-2-hydroxyethanesulfonamide [MeSH Supplementary Concept]
- N-3-oxobutylcytisine [MeSH Supplementary Concept]
- N-4-fluorobenzyl cytisine [MeSH Supplementary Concept]
- N-methylcytisine [MeSH Supplementary Concept]
- NSC156627 [MeSH Supplementary Concept]
- PVD 2908 [MeSH Supplementary Concept]
- QA 241 [MeSH Supplementary Concept]
- RS86017 [MeSH Supplementary Concept]
- S 25932 [MeSH Supplementary Concept]
- WM130 compound [MeSH Supplementary Concept]
- YNS 15P [MeSH Supplementary Concept]
- alkaloid 217A [MeSH Supplementary Concept]
- allomatrine [MeSH Supplementary Concept]
- anagyrine [MeSH Supplementary Concept]
- araguspongine C [MeSH Supplementary Concept]
- araguspongine K [MeSH Supplementary Concept]
- araguspongine L [MeSH Supplementary Concept]
- astonilin [MeSH Supplementary Concept]
- baptifoline [MeSH Supplementary Concept]
- benofloxacin [MeSH Supplementary Concept]
- benzquinamide [MeSH Supplementary Concept]
- carboline-benzoquinolizidine alkolid deoxytubulosine [MeSH Supplementary Concept]
- carmegliptin [MeSH Supplementary Concept]
- chilocorine C [MeSH Supplementary Concept]
- clathryimine A [MeSH Supplementary Concept]
- clavepictine A [MeSH Supplementary Concept]
- clavepictine B [MeSH Supplementary Concept]
- clavolonine [MeSH Supplementary Concept]
- coumarin 480 [MeSH Supplementary Concept]
- cytisine [MeSH Supplementary Concept]
- deacetylpaniculine [MeSH Supplementary Concept]
- deoxynupharidine [MeSH Supplementary Concept]
- diarylmethylenequinolizidine quaternary ammonium salts [MeSH Supplementary Concept]
- dibenzo(a,g)quinolizin-8-one [MeSH Supplementary Concept]
- diclonium bromide [MeSH Supplementary Concept]
- dithiane [MeSH Supplementary Concept]
- dolasetron [MeSH Supplementary Concept]
- epiquinamide [MeSH Supplementary Concept]
- fleephilone [MeSH Supplementary Concept]
- guiaflavine [MeSH Supplementary Concept]
- himeradine A [MeSH Supplementary Concept]
- huperzine F [MeSH Supplementary Concept]
- hydrodolasetron [MeSH Supplementary Concept]
- hyperaspine [MeSH Supplementary Concept]
- ibafloxacin [MeSH Supplementary Concept]
- indolo(2,3-b)-quinolizinium bromide [MeSH Supplementary Concept]
- julandine [MeSH Supplementary Concept]
- lannotinidine H [MeSH Supplementary Concept]
- lannotinidine I [MeSH Supplementary Concept]
- lannotinidine J [MeSH Supplementary Concept]
- lasubin I [MeSH Supplementary Concept]
- levonadifloxacin [MeSH Supplementary Concept]
- luminarin 3 [MeSH Supplementary Concept]
- lycopodine [MeSH Supplementary Concept]
- mecambridine [MeSH Supplementary Concept]
- methoxymecambridine [MeSH Supplementary Concept]
- myrtine [MeSH Supplementary Concept]
- nadifloxacin [MeSH Supplementary Concept]
- nolinium bromide [MeSH Supplementary Concept]
- obscurumine O [MeSH Supplementary Concept]
- octahydrobenzo(c)quinolizin-3-one [MeSH Supplementary Concept]
- oxymatrine [MeSH Supplementary Concept]
- paniculine [MeSH Supplementary Concept]
- phellodendrine [MeSH Supplementary Concept]
- phenanthroquinolizidine [MeSH Supplementary Concept]
- quinizolate [MeSH Supplementary Concept]
- quinotolast [MeSH Supplementary Concept]
- rhombifoline [MeSH Supplementary Concept]
- ro 19-8022 [MeSH Supplementary Concept]
- ro 195686 [MeSH Supplementary Concept]
- ro 4-1398 [MeSH Supplementary Concept]
- ro 41-3290 [MeSH Supplementary Concept]
- ro 41-3696 [MeSH Supplementary Concept]
- tangutorine [MeSH Supplementary Concept]
- thiaton [MeSH Supplementary Concept]
- thiolupinine [MeSH Supplementary Concept]
- upenamide [MeSH Supplementary Concept]
- vatinoxan [MeSH Supplementary Concept]
- vintoperol [MeSH Supplementary Concept]
- win 63480 [MeSH Supplementary Concept]
- worenine [MeSH Supplementary Concept]
- wy 25309 [MeSH Supplementary Concept]
- wy 26392 [MeSH Supplementary Concept]
- wy 26703 [MeSH Supplementary Concept]
- wy 27127 [MeSH Supplementary Concept]
See also (suggested by CISMeF)
- quinolines [MeSH Descriptor]
Semantic type(s)
- Organic Chemical [UMLS semantic type]
UMLS correspondences (same concept)
- Product containing quinolizine (product) [SNOMED CT concept]
- Quinolizine (substance) [SNOMED CT concept]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients